A prior section 2601 of act July 1, 1944, was successively renumbered by subsequent acts and transferred, see section 238 of this title.
2009—Puspan. L. 111–87 repealed Puspan. L. 109–415, § 703, and revived the provisions of this section as in effect on Sept. 30, 2009. See 2006 Amendment note and Effective Date of 2009 Amendment; Revival of Section note below.
2006—Puspan. L. 109–415, § 703, which directed repeal of this section effective Oct. 1, 2009, was itself repealed by Puspan. L. 111–87, § 2(a)(1), effective Sept. 30, 2009.
Subsec. (a). Puspan. L. 109–415, § 702(1), substituted “AIDS” for “acquired immune deficiency syndrome”.
Puspan. L. 109–415, § 106(a), substituted “during the most recent period” for “for the most recent period”.
Puspan. L. 109–415, § 101(span), substituted “through (c)” for “through (d)” and inserted “and confirmed by” after “reported to”.
Subsecs. (span) to (d). Puspan. L. 109–415, §§ 101(a), 107(span), added subsecs. (span) and (c), substituted “this subpart” for “this part” in subsec. (c) wherever appearing, and struck out former subsecs. (span) to (d) which related to requirement regarding confirmation of cases, requirements regarding population, and continued status as eligible area, respectively.
1996—Subsec. (a). Puspan. L. 104–146, § 12(c)(1), inserted “section” before “300ff–14”.
Puspan. L. 104–146, § 3(a)(1)(B), substituted “metropolitan area for which there has been reported to the Director of the Centers for Disease Control and Prevention a cumulative total of more than 2,000 cases of acquired immune deficiency syndrome for the most recent period of 5 calendar years for which such data are available.” for “metropolitan area for which, as of June 30, 1990, in the case of grants for fiscal year 1991, and as of March 31 of the most recent fiscal year for which such data is available in the case of a grant for any subsequent fiscal year—
“(1) there has been reported to and confirmed by the Director of the Centers for Disease Control and Prevention a cumulative total of more than 2,000 cases of acquired immune deficiency syndrome; or
“(2) the per capita incidence of cumulative cases of such syndrome (computed on the basis of the most recently available data on the population of the area) is not less than 0.0025.”
Puspan. L. 104–146, § 3(a)(1)(A), substituted “subject to subsections (span) through (d)” for “subject to subsection (span)”.
Subsecs. (c), (d). Puspan. L. 104–146, § 3(a)(2), added subsecs. (c) and (d).
1992—Subsecs. (a)(1), (span). Puspan. L. 102–531 substituted “Centers for Disease Control and Prevention” for “Centers for Disease Control”.
Puspan. L. 111–87, § 2(a)(2), (3), Oct. 30, 2009, 123 Stat. 2885, provided that:
Puspan. L. 109–415, title VII, § 703, Dec. 19, 2006, 120 Stat. 2820, which provided for the repeal of this subchapter effective Oct. 1, 2009, was itself repealed by Puspan. L. 111–87, § 2(a)(1), Oct. 30, 2009, 123 Stat. 2885.
Puspan. L. 104–146, § 13, May 20, 1996, 110 Stat. 1374, provided that:
Puspan. L. 106–345, title V, § 501, Oct. 20, 2000, 114 Stat. 1352, required the Secretary of Health and Human Services to request the Institute of Medicine or another appropriate entity to conduct a study of State surveillance systems on the prevalence of HIV and a study concerning the relationship between epidemiological measures and health care for certain individuals with HIV and to ensure that the former study be completed and a report submitted to congressional committees not later than 3 years after Oct. 20, 2000, and that the latter study be completed and a report submitted to congressional committees not later than 2 years after Oct. 20, 2000.
Puspan. L. 101–381, title IV, § 403, Aug. 18, 1990, 104 Stat. 622 directed Secretary of Health and Human Services, after consultation with Director of the Office of Rural Health Policy, to conduct study for purpose of estimating incidence and prevalence in rural areas of cases of acquired immune deficiency syndrome and cases of infection with etiologic agent for such syndrome and determine adequacy in rural areas of services for diagnosing and providing treatment for such cases that are in early stages of infection, and provided that, not later than 1 year after Aug. 18, 1990, Secretary was to submit report to Congress.